Maria Falck has extensive experience in life science, biomarker imaging, business development, and industry experience from CRO companies. She joins Lumito from Qlucore AB, a listed company specialising in bioinformatics for research, precision medicine, and companion diagnostics. The recruitment of Falck is a central part of Lumito’s strategy to strengthen the Company’s commercial organisation and intensify the market establishment of SCIZYS. Falck will assume her role at Lumito on 2 December 2025.
 
Upon Falck’s appointment, Anders Wallseth will step down from his role as Chief Commercial Officer and leave Lumito’s executive management team but will remain with the Company as Senior Commercial Advisor.

“We are very pleased to welcome Maria as Chief Business Officer. Maria’s combination of scientific expertise, commercial acumen, and understanding of precision diagnostics, as well as her experience from CRO companies, makes her a strong addition to our continued growth journey. Her background and experience will be of great value as we advance our market introduction efforts and work to establish ourselves as a reliable player in tissue analysis.
 
At the same time, I would like to extend my warm thanks to Anders Wallseth for his significant contributions as Chief Commercial Officer. Anders has played a central role in developing our commercial strategy, and I am very pleased that we will continue to benefit from his expertise in his role as Senior Commercial Advisor. This change strengthens our organisation and provides us with the best possible conditions for commercial acceleration,” says Sanna Wallenborg, CEO of Lumito.